Loading…
Quantitative Structure–Activity Relationship Analysis and Validation of New DNA Gyrase Inhibitors
Quantitative structure–activity relationship (QSAR) analysis was carried out for a series of 61 compounds with thiazole and benzthiazole moiety for inhibition of the DNA gyrase enzyme of Escherichia coli . The study was performed by conducting multiple linear regression analysis and followed by vali...
Saved in:
Published in: | Pharmaceutical chemistry journal 2021-12, Vol.55 (9), p.886-907 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c281t-e8679b5fa5b91f99889dadd78ee73938d22b4cd7a28e9ef0508c283e1fb8c5a53 |
container_end_page | 907 |
container_issue | 9 |
container_start_page | 886 |
container_title | Pharmaceutical chemistry journal |
container_volume | 55 |
creator | Bhuvaneswari, S. Aakash, V. Bala Ramalakshmi, N. Arunkumar, S. |
description | Quantitative structure–activity relationship (QSAR) analysis was carried out for a series of 61 compounds with thiazole and benzthiazole moiety for inhibition of the DNA gyrase enzyme of
Escherichia coli
. The study was performed by conducting multiple linear regression analysis and followed by validation of the models by OCED principles. Four models were selected as the best with
r
2
values greater than 0.7. Validation was performed by the leave-one-out method to ensure stability. The predictive power was examined by the Golbraikh and Tropsha conditions. Reliability of the models was checked by constructing Williams plots. The Y-randomization and prediction error based validation were also performed. All the four selected models had
r
2
values greater than 0.74 and
Q
2
values greater than or equal to 0.66. All models obeyed the Golbraikh and Tropsha conditions. The compounds were found to lie within the warning leverage in the Williams plot. The Y-randomization also resulted in values above 0.6, and model 1 was found to be good in prediction error based validation. Compounds with thiazole and benzthiazole moiety proved to inhibit DNA gyrase enzyme as a lead molecule. Lead optimization can be performed by designing new compounds based on the obtained QSAR results. |
doi_str_mv | 10.1007/s11094-021-02513-x |
format | article |
fullrecord | <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracacademiconefile_A691222221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A691222221</galeid><sourcerecordid>A691222221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c281t-e8679b5fa5b91f99889dadd78ee73938d22b4cd7a28e9ef0508c283e1fb8c5a53</originalsourceid><addsrcrecordid>eNp9kEtOwzAQQC0EEqVwAVa-QIodN429jMqvUlXEV-wsxxm3rtKksl1odtyBG3IS3JY1MxqNNDNvFg-hS0oGlJD8ylNKxDAhKY2VUZZsj1CPZjlLBGH0GPUIETShGXk_RWfeLwmJGEt7SD9uVBNsUMF-AH4ObqPDxsHP13eh48iGDj9BHbdt4xd2jYtG1Z23Hqumwm-qttV-h1uDZ_CJr2cFvuuc8oAnzcKWNrTOn6MTo2oPF3-9j15vb17G98n04W4yLqaJTjkNCfBRLsrMqKwU1AjBuahUVeUcIGeC8SpNy6GucpVyEGBIRngEGVBTcp2pjPXR4PB3rmqQtjFtcErHrGBldduAsXFejARNd0EjkB4A7VrvHRi5dnalXCcpkTuv8uBVRq9y71VuI8QOkI_HzRycXLYbF7X4_6hfh7l-dg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Quantitative Structure–Activity Relationship Analysis and Validation of New DNA Gyrase Inhibitors</title><source>Springer Link</source><creator>Bhuvaneswari, S. ; Aakash, V. Bala ; Ramalakshmi, N. ; Arunkumar, S.</creator><creatorcontrib>Bhuvaneswari, S. ; Aakash, V. Bala ; Ramalakshmi, N. ; Arunkumar, S.</creatorcontrib><description>Quantitative structure–activity relationship (QSAR) analysis was carried out for a series of 61 compounds with thiazole and benzthiazole moiety for inhibition of the DNA gyrase enzyme of
Escherichia coli
. The study was performed by conducting multiple linear regression analysis and followed by validation of the models by OCED principles. Four models were selected as the best with
r
2
values greater than 0.7. Validation was performed by the leave-one-out method to ensure stability. The predictive power was examined by the Golbraikh and Tropsha conditions. Reliability of the models was checked by constructing Williams plots. The Y-randomization and prediction error based validation were also performed. All the four selected models had
r
2
values greater than 0.74 and
Q
2
values greater than or equal to 0.66. All models obeyed the Golbraikh and Tropsha conditions. The compounds were found to lie within the warning leverage in the Williams plot. The Y-randomization also resulted in values above 0.6, and model 1 was found to be good in prediction error based validation. Compounds with thiazole and benzthiazole moiety proved to inhibit DNA gyrase enzyme as a lead molecule. Lead optimization can be performed by designing new compounds based on the obtained QSAR results.</description><identifier>ISSN: 0091-150X</identifier><identifier>EISSN: 1573-9031</identifier><identifier>DOI: 10.1007/s11094-021-02513-x</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Analysis ; DNA ; Medicine ; Organic Chemistry ; Pharmacology/Toxicology ; Pharmacy</subject><ispartof>Pharmaceutical chemistry journal, 2021-12, Vol.55 (9), p.886-907</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>COPYRIGHT 2021 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c281t-e8679b5fa5b91f99889dadd78ee73938d22b4cd7a28e9ef0508c283e1fb8c5a53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Bhuvaneswari, S.</creatorcontrib><creatorcontrib>Aakash, V. Bala</creatorcontrib><creatorcontrib>Ramalakshmi, N.</creatorcontrib><creatorcontrib>Arunkumar, S.</creatorcontrib><title>Quantitative Structure–Activity Relationship Analysis and Validation of New DNA Gyrase Inhibitors</title><title>Pharmaceutical chemistry journal</title><addtitle>Pharm Chem J</addtitle><description>Quantitative structure–activity relationship (QSAR) analysis was carried out for a series of 61 compounds with thiazole and benzthiazole moiety for inhibition of the DNA gyrase enzyme of
Escherichia coli
. The study was performed by conducting multiple linear regression analysis and followed by validation of the models by OCED principles. Four models were selected as the best with
r
2
values greater than 0.7. Validation was performed by the leave-one-out method to ensure stability. The predictive power was examined by the Golbraikh and Tropsha conditions. Reliability of the models was checked by constructing Williams plots. The Y-randomization and prediction error based validation were also performed. All the four selected models had
r
2
values greater than 0.74 and
Q
2
values greater than or equal to 0.66. All models obeyed the Golbraikh and Tropsha conditions. The compounds were found to lie within the warning leverage in the Williams plot. The Y-randomization also resulted in values above 0.6, and model 1 was found to be good in prediction error based validation. Compounds with thiazole and benzthiazole moiety proved to inhibit DNA gyrase enzyme as a lead molecule. Lead optimization can be performed by designing new compounds based on the obtained QSAR results.</description><subject>Analysis</subject><subject>DNA</subject><subject>Medicine</subject><subject>Organic Chemistry</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><issn>0091-150X</issn><issn>1573-9031</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kEtOwzAQQC0EEqVwAVa-QIodN429jMqvUlXEV-wsxxm3rtKksl1odtyBG3IS3JY1MxqNNDNvFg-hS0oGlJD8ylNKxDAhKY2VUZZsj1CPZjlLBGH0GPUIETShGXk_RWfeLwmJGEt7SD9uVBNsUMF-AH4ObqPDxsHP13eh48iGDj9BHbdt4xd2jYtG1Z23Hqumwm-qttV-h1uDZ_CJr2cFvuuc8oAnzcKWNrTOn6MTo2oPF3-9j15vb17G98n04W4yLqaJTjkNCfBRLsrMqKwU1AjBuahUVeUcIGeC8SpNy6GucpVyEGBIRngEGVBTcp2pjPXR4PB3rmqQtjFtcErHrGBldduAsXFejARNd0EjkB4A7VrvHRi5dnalXCcpkTuv8uBVRq9y71VuI8QOkI_HzRycXLYbF7X4_6hfh7l-dg</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Bhuvaneswari, S.</creator><creator>Aakash, V. Bala</creator><creator>Ramalakshmi, N.</creator><creator>Arunkumar, S.</creator><general>Springer US</general><general>Springer</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20211201</creationdate><title>Quantitative Structure–Activity Relationship Analysis and Validation of New DNA Gyrase Inhibitors</title><author>Bhuvaneswari, S. ; Aakash, V. Bala ; Ramalakshmi, N. ; Arunkumar, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c281t-e8679b5fa5b91f99889dadd78ee73938d22b4cd7a28e9ef0508c283e1fb8c5a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analysis</topic><topic>DNA</topic><topic>Medicine</topic><topic>Organic Chemistry</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhuvaneswari, S.</creatorcontrib><creatorcontrib>Aakash, V. Bala</creatorcontrib><creatorcontrib>Ramalakshmi, N.</creatorcontrib><creatorcontrib>Arunkumar, S.</creatorcontrib><collection>CrossRef</collection><jtitle>Pharmaceutical chemistry journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhuvaneswari, S.</au><au>Aakash, V. Bala</au><au>Ramalakshmi, N.</au><au>Arunkumar, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantitative Structure–Activity Relationship Analysis and Validation of New DNA Gyrase Inhibitors</atitle><jtitle>Pharmaceutical chemistry journal</jtitle><stitle>Pharm Chem J</stitle><date>2021-12-01</date><risdate>2021</risdate><volume>55</volume><issue>9</issue><spage>886</spage><epage>907</epage><pages>886-907</pages><issn>0091-150X</issn><eissn>1573-9031</eissn><abstract>Quantitative structure–activity relationship (QSAR) analysis was carried out for a series of 61 compounds with thiazole and benzthiazole moiety for inhibition of the DNA gyrase enzyme of
Escherichia coli
. The study was performed by conducting multiple linear regression analysis and followed by validation of the models by OCED principles. Four models were selected as the best with
r
2
values greater than 0.7. Validation was performed by the leave-one-out method to ensure stability. The predictive power was examined by the Golbraikh and Tropsha conditions. Reliability of the models was checked by constructing Williams plots. The Y-randomization and prediction error based validation were also performed. All the four selected models had
r
2
values greater than 0.74 and
Q
2
values greater than or equal to 0.66. All models obeyed the Golbraikh and Tropsha conditions. The compounds were found to lie within the warning leverage in the Williams plot. The Y-randomization also resulted in values above 0.6, and model 1 was found to be good in prediction error based validation. Compounds with thiazole and benzthiazole moiety proved to inhibit DNA gyrase enzyme as a lead molecule. Lead optimization can be performed by designing new compounds based on the obtained QSAR results.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s11094-021-02513-x</doi><tpages>22</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-150X |
ispartof | Pharmaceutical chemistry journal, 2021-12, Vol.55 (9), p.886-907 |
issn | 0091-150X 1573-9031 |
language | eng |
recordid | cdi_gale_infotracacademiconefile_A691222221 |
source | Springer Link |
subjects | Analysis DNA Medicine Organic Chemistry Pharmacology/Toxicology Pharmacy |
title | Quantitative Structure–Activity Relationship Analysis and Validation of New DNA Gyrase Inhibitors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T02%3A28%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantitative%20Structure%E2%80%93Activity%20Relationship%20Analysis%20and%20Validation%20of%20New%20DNA%20Gyrase%20Inhibitors&rft.jtitle=Pharmaceutical%20chemistry%20journal&rft.au=Bhuvaneswari,%20S.&rft.date=2021-12-01&rft.volume=55&rft.issue=9&rft.spage=886&rft.epage=907&rft.pages=886-907&rft.issn=0091-150X&rft.eissn=1573-9031&rft_id=info:doi/10.1007/s11094-021-02513-x&rft_dat=%3Cgale_cross%3EA691222221%3C/gale_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c281t-e8679b5fa5b91f99889dadd78ee73938d22b4cd7a28e9ef0508c283e1fb8c5a53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A691222221&rfr_iscdi=true |